Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels

Cell Metabolism

Volumn 17, Issue 6, 2013, Pages 916-928

  Vergnes, Laurent ^a   Lee, Jessica M ^a   Chin, Robert G ^a   Auwerx, Johan ^c   Reue, Karen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CELL PROTEIN; CHOLESTEROL 7ALPHA MONOOXYGENASE; COMPLEMENTARY DNA; DIET1 PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; FIBROBLAST GROWTH FACTOR 19; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BILE ACID SYNTHESIS; CELL DIFFERENTIATION; CELL METABOLISM; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENTEROHEPATIC CIRCULATION; GENE MUTATION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IN VIVO STUDY; INTESTINE CELL; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; BILE ACIDS AND SALTS; CARRIER PROTEINS; CELLS, CULTURED; CHOLESTEROL 7-ALPHA-HYDROXYLASE; ENTEROCYTES; ENTEROHEPATIC CIRCULATION; FIBROBLAST GROWTH FACTORS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

MUS;

EID: 84878789770     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.04.007     Document Type: Article

References (51)

1. S. Aggarwal, R.S. Loomba, and R.R. Arora Efficacy of colesevelam on lowering glycemia and lipids J. Cardiovasc. Pharmacol. 59 2012 198 205
2. K. Allen, K.E. Gokay, M.A. Thomas, B.A. Speelman, and J.M. Wilson Biosynthesis of endotubin: an apical early endosomal glycoprotein from developing rat intestinal epithelial cells Biochem. J. 330 1998 367 373
3. B. Angelin, M. Eriksson, and M. Rudling Bile acids and lipoprotein metabolism: a renaissance for bile acids in the post-statin era? Curr. Opin. Lipidol. 10 1999 269 274
4. B. Angelin, T.E. Larsson, and M. Rudling Circulating fibroblast growth factors as metabolic regulators - a critical appraisal Cell Metab. 16 2012 693 705
5. Y.S. Aulchenko, S. Ripatti, I. Lindqvist, D. Boomsma, I.M. Heid, P.P. Pramstaller, B.W. Penninx, A.C. Janssens, J.F. Wilson, T. Spector ENGAGE Consortium Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts Nat. Genet. 41 2009 47 55
6. G. Beckmann, and P. Bork An adhesive domain detected in functionally diverse receptors Trends Biochem. Sci. 18 1993 40 41
7. D.I. Chasman, G. Paré, S. Mora, J.C. Hopewell, G. Peloso, R. Clarke, L.A. Cupples, A. Hamsten, S. Kathiresan, and A. Mälarstig Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis PLoS Genet. 5 2009 e1000730
8. C. Cicione, C. Degirolamo, and A. Moschetta Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver Hepatology 56 2012 2404 2411
9. V.B. Cismasiu, S.A. Denes, H. Reiländer, H. Michel, and S.E. Szedlacsek The MAM (meprin/A5-protein/PTPmu) domain is a homophilic binding site promoting the lateral dimerization of receptor-like protein-tyrosine phosphatase mu J. Biol. Chem. 279 2004 26922 26931
10. S.M. Cohn, T.C. Simon, K.A. Roth, E.H. Birkenmeier, and J.I. Gordon Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium J. Cell Biol. 119 1992 27 44
11. P.A. Dawson, T. Lan, and A. Rao Bile acid transporters J. Lipid Res. 50 2009 2340 2357
12. C. Gälman, B. Angelin, and M. Rudling Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19 J. Intern. Med. 270 2011 580 588
13. K.E. Gokay, R.S. Young, and J.M. Wilson Cytoplasmic signals mediate apical early endosomal targeting of endotubin in MDCK cells Traffic 2 2001 487 500
14. A.B. Goldfine Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway Curr. Opin. Cardiol. 23 2008 502 511
15. J. Hageman, H. Herrema, A.K. Groen, and F. Kuipers A role of the bile salt receptor FXR in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 30 2010 1519 1528
16. Y. Handelsman Role of bile acid sequestrants in the treatment of type 2 diabetes Diabetes Care 34 Suppl 2 2011 S244 S250
17. A.F. Hofmann The enterohepatic circulation of bile acids in mammals: form and functions Front. Biosci. 14 2009 2584 2598
18. P.B. Hylemon, H. Zhou, W.M. Pandak, S. Ren, G. Gil, and P. Dent Bile acids as regulatory molecules J. Lipid Res. 50 2009 1509 1520
19. T. Inagaki, M. Choi, A. Moschetta, L. Peng, C.L. Cummins, J.G. McDonald, G. Luo, S.A. Jones, B. Goodwin, and J.A. Richardson Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis Cell Metab. 2 2005 217 225
20. F.T. Ishmael, V.K. Shier, S.S. Ishmael, and J.S. Bond Intersubunit and domain interactions of the meprin B metalloproteinase. Disulfide bonds and protein-protein interactions in the MAM and TRAF domains J. Biol. Chem. 280 2005 13895 13901
21. I. Johnston, J. Nolan, S.S. Pattni, and J.R. Walters New insights into bile acid malabsorption Curr. Gastroenterol. Rep. 13 2011 418 425
22. S.A. Jones Mini-review: endocrine actions of fibroblast growth factor 19 Mol. Pharm. 5 2008 42 48
23. S.A. Jones Physiology of FGF15/19 Adv. Exp. Med. Biol. 728 2012 171 182
24. S. Kathiresan, C.J. Willer, G.M. Peloso, S. Demissie, K. Musunuru, E.E. Schadt, L. Kaplan, D. Bennett, Y. Li, and T. Tanaka Common variants at 30 loci contribute to polygenic dyslipidemia Nat. Genet. 41 2009 56 65
25. S. Khurana, J.P. Raufman, and T.L. Pallone Bile acids regulate cardiovascular function Clin. Transl. Sci. 4 2011 210 218
26. I. Kim, S.H. Ahn, T. Inagaki, M. Choi, S. Ito, G.L. Guo, S.A. Kliewer, and F.J. Gonzalez Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine J. Lipid Res. 48 2007 2664 2672
27. P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of bile acids and bile acid receptors in metabolic regulation Physiol. Rev. 89 2009 147 191
28. T. Li, E. Owsley, M. Matozel, P. Hsu, C.M. Novak, and J.Y. Chiang Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice Hepatology 52 2010 678 690
29. T. Li, M. Matozel, S. Boehme, B. Kong, L.M. Nilsson, G. Guo, E. Ellis, and J.Y. Chiang Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis Hepatology 53 2011 996 1006
30. T. Lundåsen, C. Gälman, B. Angelin, and M. Rudling Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man J. Intern. Med. 260 2006 530 536
31. S.D. McCarter, D.L. Johnson, K.N. Kitt, C. Donohue, A. Adams, and J.M. Wilson Regulation of tight junction assembly and epithelial polarity by a resident protein of apical endosomes Traffic 11 2010 856 866
32. A. Mouzeyan, J. Choi, H. Allayee, X. Wang, J. Sinsheimer, J. Phan, L.W. Castellani, K. Reue, A.J. Lusis, and R.C. Davis A locus conferring resistance to diet-induced hypercholesterolemia and atherosclerosis on mouse chromosome 2 J. Lipid Res. 41 2000 573 582
33. C. Out, A.K. Groen, and G. Brufau Bile acid sequestrants: more than simple resins Curr. Opin. Lipidol. 23 2012 43 55
34. J. Phan, T. Pesaran, R.C. Davis, and K. Reue The Diet1 locus confers protection against hypercholesterolemia through enhanced bile acid metabolism J. Biol. Chem. 277 2002 469 477
35. M.J. Potthoff, J. Boney-Montoya, M. Choi, T. He, N.E. Sunny, S. Satapati, K. Suino-Powell, H.E. Xu, R.D. Gerard, and B.N. Finck FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway Cell Metab. 13 2011 729 738
36. A. Quaroni, J. Wands, R.L. Trelstad, and K.J. Isselbacher Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria J. Cell Biol. 80 1979 248 265
37. M. Rousset, M. Laburthe, M. Pinto, G. Chevalier, C. Rouyer-Fessard, E. Dussaulx, G. Trugnan, N. Boige, J.L. Brun, and A. Zweibaum Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin J. Cell. Physiol. 123 1985 377 385
38. D.W. Russell The enzymes, regulation, and genetics of bile acid synthesis Annu. Rev. Biochem. 72 2003 137 174
39. D.W. Russell Fifty years of advances in bile acid synthesis and metabolism J. Lipid Res. 50 Suppl 2009 S120 S125
40. M.S. Sandhu, D.M. Waterworth, S.L. Debenham, E. Wheeler, K. Papadakis, J.H. Zhao, K. Song, X. Yuan, T. Johnson, S. Ashford Wellcome Trust Case Control Consortium LDL-cholesterol concentrations: a genome-wide association study Lancet 371 2008 483 491
41. D.R. Schmidt, S.R. Holmstrom, K. Fon Tacer, A.L. Bookout, S.A. Kliewer, and D.J. Mangelsdorf Regulation of bile acid synthesis by fat-soluble vitamins A and D J. Biol. Chem. 285 2010 14486 14494
42. T.U. Semple, L.A. Quinn, L.K. Woods, and G.E. Moore Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model Cancer Res. 38 1978 1345 1355
43. T.M. Teslovich, K. Musunuru, A.V. Smith, A.C. Edmondson, I.M. Stylianou, M. Koseki, J.P. Pirruccello, S. Ripatti, D.I. Chasman, and C.J. Willer Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
44. C. Thomas, R. Pellicciari, M. Pruzanski, J. Auwerx, and K. Schoonjans Targeting bile-acid signalling for metabolic diseases Nat. Rev. Drug Discov. 7 2008 678 693
45. J.R. Walters, and S.S. Pattni Managing bile acid diarrhoea Therap Adv Gastroenterol 3 2010 349 357
46. J.R. Walters, A.M. Tasleem, O.S. Omer, W.G. Brydon, T. Dew, and C.W. le Roux A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis Clin. Gastroenterol. Hepatol. 7 2009 1189 1194
47. H. Westergaard Bile Acid malabsorption Curr. Treat. Options Gastroenterol. 10 2007 28 33
48. J.M. Wilson, and T.L. Colton Targeting of an intestinal apical endosomal protein to endosomes in nonpolarized cells J. Cell Biol. 136 1997 319 330
49. T.J. Wright, R. Ladher, J. McWhirter, C. Murre, G.C. Schoenwolf, and S.L. Mansour Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction Dev. Biol. 269 2004 264 275
50. T. Yamamoto, and R.O. Ryan Domain swapping reveals that low density lipoprotein (LDL) type A repeat order affects ligand binding to the LDL receptor J. Biol. Chem. 284 2009 13396 13400
51. A. Zweibaum, N. Triadou, M. Kedinger, C. Augeron, S. Robine-Léon, M. Pinto, M. Rousset, and K. Haffen Sucrase-isomaltase: a marker of foetal and malignant epithelial cells of the human colon Int. J. Cancer 32 1983 407 412